Opaleye Management’s Pasithea Therapeutics KTTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,050,000
Closed -$1.06M – 62
2026
Q2
$1.06M Buy
+2,050,000
New +$1.41M 0.1% 54

Other funds holding KTTA

Opaleye Management's KTTA Position: Q3 2026 in Review

Opaleye Management sold out of Pasithea Therapeutics (KTTA) in Q3 2026, closing a stake of 2,050,000 shares — an estimated $1.06M sold.

Opaleye Management first reported a position in KTTA in Q2 2026 and held it in 1 quarter. The position peaked at $1.06M in Q2 2026. 26 funds tracked by Wall St. Rank hold KTTA as of Q3 2026.

  • Opaleye Management reported no remaining Pasithea Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Opaleye Management sold 2,050,000 Pasithea Therapeutics shares in Q3 2026, an estimated $1.06M.
  • Opaleye Management first reported a position in Pasithea Therapeutics in Q2 2026 and held it in 1 quarter.
  • Opaleye Management's Pasithea Therapeutics position peaked at $1.06M in Q2 2026.
  • 26 funds tracked by Wall St. Rank held Pasithea Therapeutics as of Q3 2026.

Based on Opaleye Management's 13F filing for Q3 2026, filed 16 Nov 2026.